Home Company News & Events Press Releases 2011 NIH funds Tagging of Histopathology Speciments at PharmaSeq

Press Releases

NIH funds Tagging of Histopathology Speciments at PharmaSeq

National Institutes of Health funds Tagging of Histopathology Specimens at PharmaSeq

Monmouth Junction, NJ, February 1, 2011. PharmaSeq, Inc., announced today the receipt of an Phase I SBIR grant for a project entitled "Tagging of Histopathology Specimens with Light-Activated RFID Chips". The grant was awarded by the National Institute of General Medical Sciences of the NIH [Award Number 1R43GM096580].

The main goal of the grant is to improve the method of tagging and tracking tissue samples in the biomedical laboratory. The most common methods for preserving samples are on glass microscope slides or tissue cassettes. Labeling is currently done by hand or with optical bar codes, each of which result in significant amount of time being needed to locate and retrieve samples from collections. PharmaSeq is developing a superior system that is based on its patented microtransponders or p-Chips. The p-Chip is a small, light-activated RFID chip that can easily be attached to slides and cassettes; both new and those in existing collections. When combined with a specially designed reader, the system can be used to search large collections to locate a target sample. Each p-Chip contains a unique serial number that can be equated with a specific sample using common database techniques. The goal of the grant is to provide an end-to-end system that will improve efficiency and reliability in biomedical specimen collections.

Dr. Wlodek Mandecki, President of PharmaSeq, Inc., said: "This award underlines the importance of our p-Chips and related products, and its versatility in a number of fields. We previously developed and introduced a system for tagging and labeling small animals. The extension of similar products into histology and related fields will further demonstrate the utility of the p-Chip in applied and research areas of the life sciences."

For further information, please contact Dr. Richard Morris, CEO, or Dr. Wlodek Mandecki, President, at (732) 355-0100 ext 11.

PharmaSeq, Inc.
11 Deer Park Drive, Suite 104
Monmouth Junction, NJ 08852
Find us on the web at:

Home Company News & Events Press Releases 2011 NIH funds Tagging of Histopathology Speciments at PharmaSeq